The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard tissue samples taken during diagnosis, finds a new study from researchers ...

UCLA research finds that fewer than one in four eligible younger adults completed colorectal cancer screenings after the ...

UCLA research finds that fewer than 1 in 4 eligible younger adults completed colorectal cancer screenings after the United States Preventive Services Task Force (USPSTF) lowered the recommended ...

Artificial intelligence (AI) can predict how well patients with rectal cancer will respond to treatment by analyzing standard ...

Women under age 50 who consume higher amounts of ultraprocessed foods (UPFs) face significantly increased odds of developing ...

Scientists are turning venom, radioisotopes, engineered proteins, and AI into powerful new tools against cancer. From ...

Funding advances Phase 2 expansion cohorts in pancreatic and colorectal cancer in ATM-negative patients for Artios’ potential first-in-class ATR Inhibitor, alnodesertib Following encouraging ESMO data ...

Artios Pharma, which looking for newer targets that, like PARP inhibitors, affect the way tumors fix themselves, said its ...

Dr. Jessica Shepherd, chief medical officer for Hers, joins ABC News Live to discuss ultra-processed foods and women’s health.

Please provide your email address to receive an email when new articles are posted on . Patients with rectal bleeding were 8.5 times likelier to have early-onset colorectal cancer, data show. Most ...

GREENVILLE, S.C. (FOX Carolina) - A groundbreaking device is changing how doctors treat colorectal cancer by targeting tumors while sparing the rest of the body from chemotherapy side effects. Hope ...